echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Mov Disord: Spinocerebellar ataxia type 3 severity is related to lifestyle

    Mov Disord: Spinocerebellar ataxia type 3 severity is related to lifestyle

    • Last Update: 2021-11-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Spinocerebellar ataxia type 3 (SCA3) is the most common dominant genetic ataxia, which can lead to severe disability and premature death
    .


    Although there is no effective treatment yet, several methods have been developed to reduce mutant proteins, and pilot trials seem to be within reach


    Spinocerebellar ataxia type 3 (SCA3) is the most common dominant genetic ataxia, which can lead to severe disability and premature death


    Ludger Schöls et al.


    The study collected data on smoking, drinking, physical activity, physical therapy, and body mass index (BMI) of 243 SCA3 patients and 119 control groups to detect their correlation with age of onset, disease severity, and progression
    .

    The study collected data on smoking, drinking, physical activity, physical therapy, and body mass index (BMI) of 243 SCA3 patients and 119 control groups to detect their correlation with age of onset, disease severity, and progression
    .


    Preliminary analysis of the relationship between life>
    .


    (A) Smoking is not significantly related to any outcome parameters


    Preliminary analysis of the relationship between life>


     

    Compared with the control group, SCA3 patients have less activity and drink less alcohol
    .


    Less exercise and abstinence from alcohol are associated with more serious diseases, but not with the rate of disease progression or the age of onset


    Compared with the control group, SCA3 patients have less activity and drink less alcohol


    Although this study included one of the world's largest SCA3 cohorts, it lacked longitudinal progress data


    SCA3 The difference in life> SCA3 patients and the control group and the correlation between life>


    Characterization of Life>

    Characterization of Life> Characterization of Life>Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.